Designer drugs--the "whats" and the "whys".
Chesher
G
G
Department of Pharmacology, University of Sydney, NSW.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015198:Designer Drugs; D004300:Doping in Sports; D015195:Drug Design; D005283:Fentanyl / Q000031:analogs & derivatives; D006801:Humans; D013287:Illicit Drugs; D007880:Legislation, Drug; D008614:Meperidine / Q000031:analogs & derivatives; D010627:Phenethylamines; D013329:Structure-Activity Relationship
D015198:Designer Drugs; D013287:Illicit Drugs; D010627:Phenethylamines; D008614:Meperidine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D005283:Fentanyl